Sterling Investment Advisors (Pennsylvania)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Sterling Investment Advisors (Pennsylvania)'s NVO Position: Q3 2022 in Review
Sterling Investment Advisors (Pennsylvania) sold out of Novo Nordisk (NVO) in Q3 2022, closing a stake of 120 shares — an estimated $7K sold.
Sterling Investment Advisors (Pennsylvania) first reported a position in NVO in Q1 2021 and held it in 6 quarters. The position peaked at $7K in Q2 2022. 908 funds tracked by Wall St. Rank hold NVO as of Q3 2022.
- Sterling Investment Advisors (Pennsylvania) reported no remaining Novo Nordisk position as of Q3 2022 after selling out during the quarter.
- Sterling Investment Advisors (Pennsylvania) sold 120 Novo Nordisk shares in Q3 2022, an estimated $7K.
- Sterling Investment Advisors (Pennsylvania) first reported a position in Novo Nordisk in Q1 2021 and held it in 6 quarters.
- Sterling Investment Advisors (Pennsylvania)'s Novo Nordisk position peaked at $7K in Q2 2022.
- 908 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.
Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.